194 related articles for article (PubMed ID: 32579501)
1. Neuroimaging Outcomes in Studies of Cognitive Training in Mild Cognitive Impairment and Early Alzheimer's Disease: A Systematic Review.
Beishon L; Intharakham K; Swienton D; Panerai RB; Robinson TG; Haunton VJ
Curr Alzheimer Res; 2020; 17(5):472-486. PubMed ID: 32579501
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MGEKN; Tabet N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MG; Tabet N
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer's disease: protocol for a rapid systematic review.
Ahmadzadeh M; Christie GJ; Cosco TD; Moreno S
Syst Rev; 2020 Apr; 9(1):71. PubMed ID: 32241302
[TBL] [Abstract][Full Text] [Related]
5. The effects of noninvasive brain stimulation on cognitive function in patients with mild cognitive impairment and Alzheimer's disease using resting-state functional magnetic resonance imaging: A systematic review and meta-analysis.
Wang T; Yan S; Lu J
CNS Neurosci Ther; 2023 Nov; 29(11):3160-3172. PubMed ID: 37349974
[TBL] [Abstract][Full Text] [Related]
6. Effects of computerized cognitive training on neuroimaging outcomes in older adults: a systematic review.
Ten Brinke LF; Davis JC; Barha CK; Liu-Ambrose T
BMC Geriatr; 2017 Jul; 17(1):139. PubMed ID: 28693437
[TBL] [Abstract][Full Text] [Related]
7. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures.
Sherman DS; Mauser J; Nuno M; Sherzai D
Neuropsychol Rev; 2017 Dec; 27(4):440-484. PubMed ID: 29282641
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis.
Duan Y; Lu L; Chen J; Wu C; Liang J; Zheng Y; Wu J; Rong P; Tang C
BMC Geriatr; 2018 Aug; 18(1):175. PubMed ID: 30086714
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment: a critical review.
Canu E; Sarasso E; Filippi M; Agosta F
Alzheimers Res Ther; 2018 Feb; 10(1):21. PubMed ID: 29458420
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of strengths and limitations of randomized controlled trials for non-pharmacological interventions in mild cognitive impairment: focus on Alzheimer's disease.
Horr T; Messinger-Rapport B; Pillai JA
J Nutr Health Aging; 2015 Feb; 19(2):141-53. PubMed ID: 25651439
[TBL] [Abstract][Full Text] [Related]
12. The optimal treatment for improving cognitive function in elder people with mild cognitive impairment incorporating Bayesian network meta-analysis and systematic review.
Liang JH; Shen WT; Li JY; Qu XY; Li J; Jia RX; Wang YQ; Wang S; Wu RK; Zhang HB; Hang L; Xu Y; Lin L
Ageing Res Rev; 2019 May; 51():85-96. PubMed ID: 30682429
[TBL] [Abstract][Full Text] [Related]
13. Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.
Kapoor A; Bartha R; Black SE; Borrie M; Freedman M; Gao F; Herrmann N; Mandzia J; Ozzoude M; Ramirez J; Scott CJM; Symons S; Fischer CE; Frank A; Seitz D; Wolf MU; Verhoeff NPLG; Naglie G; Reichman W; Masellis M; Mitchell SB; Tang-Wai DF; Tartaglia MC; Kumar S; Pollock BG; Rajji TK; Finger E; Pasternak SH; ; Swartz RH
J Alzheimers Dis; 2020; 74(3):747-757. PubMed ID: 32116253
[TBL] [Abstract][Full Text] [Related]
14. Enhancing cognitive training effects in Alzheimer's disease: rTMS as an add-on treatment.
Bagattini C; Zanni M; Barocco F; Caffarra P; Brignani D; Miniussi C; Defanti CA
Brain Stimul; 2020; 13(6):1655-1664. PubMed ID: 33002645
[TBL] [Abstract][Full Text] [Related]
15. Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease.
Skillbäck T; Kornhuber J; Blennow K; Zetterberg H; Lewczuk P;
J Alzheimers Dis; 2019; 69(2):551-559. PubMed ID: 31104027
[TBL] [Abstract][Full Text] [Related]
16. White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.
van den Berg E; Geerlings MI; Biessels GJ; Nederkoorn PJ; Kloppenborg RP
J Alzheimers Dis; 2018; 63(2):515-527. PubMed ID: 29630548
[TBL] [Abstract][Full Text] [Related]
17. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
[TBL] [Abstract][Full Text] [Related]
18. Effect of computerised cognitive training on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis.
Zhang H; Huntley J; Bhome R; Holmes B; Cahill J; Gould RL; Wang H; Yu X; Howard R
BMJ Open; 2019 Aug; 9(8):e027062. PubMed ID: 31427316
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
